Alkem Laboratories has introduced the original De Simone formulation to India, marking a strong move into the country’s fast-rising gut-health market. The launch comes at a time when digestive disorders are climbing and consumer awareness around...
HRV Pharma has announced a significant CDMO partnership with MetroChem API, marking one of India’s standout moves in advanced API development. Revealed today, the multi-year agreement positions HRV Pharma’s Virtual API platform alongside...
Kailash Hospital & Heart Institute in Noida has been awarded the NABH Digital Health Gold Certification by the National Accreditation Board for Hospitals & Healthcare Providers, placing it among the country’s leading digital healthcare institutions
.png)
Zydus Lifesciences and SIG have introduced a major advancement in pharmaceutical packaging with a single-serve format for liquid cough and cold medication. The launch leverages SIG’s tethered spout solution SIG StrawCap 30 Linked and Motion...
.png)
AstraZeneca Pharma India and Sun Pharmaceutical Industries have struck a second brand partnership to broaden access to sodium zirconium cyclosilicate (SZC), a critical therapy for hyperkalaemia, across India. Under this deal, AstraZeneca will...
Following the historic approval granted in August 2025 by India’s Central Drugs Standard Control Organization (CDSCO), Shilpa Medicare has launched NODUCA (Nor Ursodeoxycholic Acid, or norUDCA), the first medication of its kind to be introduced in
Zydus Lifesciences has secured final approval from the United States Food and Drug Administration (USFDA) for its Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial, the generic equivalent of Lupron Injection (1 mg/0.2 mL)
Merck is reportedly nearing an agreement to acquire Cidara Therapeutics, in a deal that would value the biotechnology firm above its current $3.3 billion market capitalization
CN Tech Engineers (CN Water), a major Indian provider of high-purity water solutions for pharmaceutical and industrial use, has entered into a strategic alliance with Taiwan Pure Water Technology Co., Ltd. (Taipure), a leader in ultrapure water (UPW)
The US Food and Drug Administration (USFDA) has finally approved Alembic Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Dexlansoprazole Delayed-Release Capsules
.jpg)
.jpg)
, CDSCO.jpg)